Treatment

TT-702 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1, PHASE2
TT-702 in Patients With Advanced Solid Tumours.
This study is testing a new drug, TT-702, for people with advanced cancers. We want to find a safe dose of TT-702, by itself and with another drug called darolutamide, and see how it affects tumours.
For: Advanced Solid Tumors
United Kingdom